Michael R Hamblin1, Scott T Nelson2, Justin R Strahan2. 1. 1 Department of Dermatology, Wellman Center for Photomedicine , Massachusetts General Hospital, Boston, Massachusetts. 2. 2 Joovv Inc., Crystal, Minnesota.
Abstract
BACKGROUND: Photobiomodulation (PBM) therapy is a rapidly growing approach to stimulate healing, reduce pain, increase athletic performance, and improve general wellness. OBJECTIVE: Applying PBM therapy over the site of a tumor has been considered to be a contraindication. However, since another growing use of PBM therapy is to mitigate the side effects of cancer therapy, this short review seeks to critically examine the evidence of whether PBM therapy is beneficial or harmful in cancer patients. MATERIALS AND METHODS: PubMed and Google Scholar were searched. RESULTS: Although there are a few articles suggesting that PBM therapy can be detrimental in animal models of tumors, there are also many articles that suggest the opposite and that light can directly damage the tumor, can potentiate other cancer therapies, and can stimulate the host immune system. Moreover, there are two clinical trials showing increased survival in cancer patients who received PBM therapy. CONCLUSIONS: PBM therapy may have benefits in cancer patients and should be further investigated.
BACKGROUND: Photobiomodulation (PBM) therapy is a rapidly growing approach to stimulate healing, reduce pain, increase athletic performance, and improve general wellness. OBJECTIVE: Applying PBM therapy over the site of a tumor has been considered to be a contraindication. However, since another growing use of PBM therapy is to mitigate the side effects of cancer therapy, this short review seeks to critically examine the evidence of whether PBM therapy is beneficial or harmful in cancerpatients. MATERIALS AND METHODS: PubMed and Google Scholar were searched. RESULTS: Although there are a few articles suggesting that PBM therapy can be detrimental in animal models of tumors, there are also many articles that suggest the opposite and that light can directly damage the tumor, can potentiate other cancer therapies, and can stimulate the host immune system. Moreover, there are two clinical trials showing increased survival in cancerpatients who received PBM therapy. CONCLUSIONS:PBM therapy may have benefits in cancerpatients and should be further investigated.
Entities:
Keywords:
antitumor immune response; cancer; cancer therapy side effects; contraindication; low-level laser therapy; photobiomodulation
Authors: Judith A E M Zecha; Judith E Raber-Durlacher; Raj G Nair; Joel B Epstein; Stephen T Sonis; Sharon Elad; Michael R Hamblin; Andrei Barasch; Cesar A Migliorati; Dan M J Milstein; Marie-Thérèse Genot; Liset Lansaat; Ron van der Brink; Josep Arnabat-Dominguez; Lisette van der Molen; Irene Jacobi; Judi van Diessen; Jan de Lange; Ludi E Smeele; Mark M Schubert; René-Jean Bensadoun Journal: Support Care Cancer Date: 2016-03-16 Impact factor: 3.603
Authors: Stephen T Sonis; Sepehr Hashemi; Joel B Epstein; Raj G Nair; Judith E Raber-Durlacher Journal: Oral Oncol Date: 2016-02-03 Impact factor: 5.337
Authors: Luis A Santana-Blank; Elizabeth Rodríguez-Santana; Fernando Vargas; Heberto Reyes; Pablo Fernández-Andrade; Saide Rukos; Karin E Santana-Rodríguez Journal: Clin Cancer Res Date: 2002-10 Impact factor: 12.531
Authors: Michael Staelens; Elisabetta Di Gregorio; Aarat P Kalra; Hoa T Le; Nazanin Hosseinkhah; Mahroo Karimpoor; Lew Lim; Jack A Tuszyński Journal: Front Med Technol Date: 2022-05-04
Authors: Marwan El Mobadder; Fadi Farhat; Wassim El Mobadder; Samir Nammour Journal: Int J Environ Res Public Health Date: 2019-11-15 Impact factor: 3.390
Authors: Elisa Kauark-Fontes; Cesar Augusto Migliorati; Joel B Epstein; Nathaniel Simon Treister; Carolina Guimarães Bonfim Alves; Karina Morais Faria; Natalia Rangel Palmier; Leticia Rodrigues-Oliveira; Mariana de Pauli Paglioni; Luiz Alcino Monteiro Gueiros; Karina G M da Conceição Vasconcelos; Gilberto de Castro; Adriana Franco Paes Leme; Marcio Ajudarte Lopes; Ana Carolina Prado-Ribeiro; Thaís Bianca Brandão; Alan Roger Santos-Silva Journal: Support Care Cancer Date: 2021-10-28 Impact factor: 3.603